FDA Grants Priority Review to Huntington Disease Gene Therapy BLA, Sevasemten Misses Primary, Secondary End Points in BMD, Overviewing the 1-Year KYSA-8 Findings

07 Nov 2026 0 comments

Neurology News Network for the week ending November 7th, 2026. [WATCH TIME: 5 minutes]

Source: NeurologyLive Published 07 Nov 2026 Imported 07 Nov 2026 Relevancy: Not reviewed

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.